ALI-JACKSON KAMIL sold 16.5% of their position (2.50K shares) of RIGEL PHARMACEUTICALS INC on the open market
Open‑market sale worth $72.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/28/2026ACC: 0000905148-26-002724
Director
Since Dec 2021
-2.50K
Net shares
Net seller
$72.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.50K
Price / share
$29.17
Trade value
$72.92K
% of position
16.5%
5/26/2026
15.13K→12.63K
Total
Net shares
−2.50K
Net value
-$72.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | S · Sale | −2.50K | $29.17 | $72.92K | 16.5% | 15.13K | 12.63K |
| Total | −2.50K | -$72.92K | ||||||
Derivative Transactions0
No derivative transactions reported